CLASS II Device recall · Reported 1 Jan 2020 · FDA Enforcement Report

7% BSA (Bovine Serum Albumin), Product recalled

Ortho Clinical Diagnostics is recalling 7% BSA (Bovine Serum Albumin), distributed nationwide in the US. The recall was initiated on 14 Oct 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot with Expiry Date: D6289 2019-11-20 E6382 2020-01-15 F6602 2020-05-02 G6679 2020-08-13 H6897 2020-10-01 J7129 2021-01-23 K7421 2021-07-01 L7592 2021-08-26
Quantity recalled16,584

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0739-2020
FDA event ID
84123
Recalling firm
Ortho Clinical Diagnostics, Raritan, NJ
Classification
Class II
Status
Terminated
Recall initiated
14 Oct 2019
FDA classified
26 Dec 2019
Reported
1 Jan 2020
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Reason category
Potency & Assay

Timeline

14 Oct 2019Recall initiated by company
26 Dec 2019Classified by FDA+73 days
1 Jan 2020Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Potential for the instability of the diluents VITROS 7% BSA (Product Code 8262487) and VITROS Urine Electrolyte Diluent (UED) (Product Code 1110352) when stored in a 2mL cup for 7 days

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

7% BSA (Bovine Serum Albumin), Product Code: 8262487 - Product Usage: is used to dilute samples when assay values exceed the reportable (dynamic) range using the VITROS 250/350/5,1 FS/4600 Chemistry Systems and VITROS 5600/XT 7600 Integrated Systems.

Where it was distributed

Worldwide distribution - US Nationwide distribution and countries BM, AU, BR, CA, CL, CN, CO, IN, JP, MX, SG, GB, FR, DE, IT, ES, PT, PL, RU, DK, NO, SE, BE, NL.

Nationwide CaliforniaColoradoDelawareIndiana

Questions about this recall

Why was it recalled?

Potential for the instability of the diluents VITROS 7% BSA (Product Code 8262487) and VITROS Urine Electrolyte Diluent (UED) (Product Code 1110352) when stored in a 2mL cup for 7 days

Which lots are affected?

Lot with Expiry Date: D6289 2019-11-20 E6382 2020-01-15 F6602 2020-05-02 G6679 2020-08-13 H6897 2020-10-01 J7129 2021-01-23 K7421 2021-07-01 L7592 2021-08-26

Where was it sold?

Worldwide distribution - US Nationwide distribution and countries BM, AU, BR, CA, CL, CN, CO, IN, JP, MX, SG, GB, FR, DE, IT, ES, PT, PL, RU, DK, NO, SE, BE, NL.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

1 other product · FDA event 84123

This product is part of a recall event; the main page for the event is Urine Electrolyte Diluent, Product recalled.

ReportedClassRecallCompanyReasonWhere
CLASS IIUrine Electrolyte Diluent, Product recalledOrtho Clinical DiagnosticsPotency & AssayNationwide

More recalls from Ortho Clinical Diagnostics

All 311

Other Test Kits & Diagnostics recalls

All 2,656